Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 3 , Pages 201-207 , September 2008

Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images

  • Tatjana Paunesku, PhD

      Affiliations

    • Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA
    • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Tianyi Ke, PhD

      Affiliations

    • Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah, USA
  • ,
  • Rohan Dharmakumar, PhD

      Affiliations

    • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Nicole Mascheri, MS

      Affiliations

    • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Aiguo Wu, PhD

      Affiliations

    • Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Barry Lai, PhD

      Affiliations

    • X-ray Science Division, Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois, USA
  • ,
  • Stefan Vogt, PhD

      Affiliations

    • X-ray Science Division, Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois, USA
  • ,
  • Jörg Maser, PhD

      Affiliations

    • X-ray Science Division, Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois, USA
  • ,
  • Kenneth Thurn, BS

      Affiliations

    • Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Barbara Szolc-Kowalska, MD

      Affiliations

    • Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Andrew Larson, PhD

      Affiliations

    • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Raymond C. Bergan, PhD

      Affiliations

    • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA
    • Department of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Reed Omary, MD, MS

      Affiliations

    • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA
    • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Debiao Li, PhD

      Affiliations

    • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
  • ,
  • Zheng-Rong Lu, PhD

      Affiliations

    • Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah, USA
  • ,
  • Gayle E. Woloschak, PhD

      Affiliations

    • Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA
    • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    • Department of Cell and Molecular Biology, Northwestern University, Chicago, Illinois, USA
    • Corresponding Author InformationCorresponding author. Department of Cell and Molecular Biology, Northwestern University, Chicago, IL 60611, USA.

Received 15 September 2007 ,Accepted 13 April 2008.

References 

  1. Fuster V, Kim RJ. Frontiers in cardiovascular magnetic resonance. Circulation. 2005;112:135–144
  2. McDonald MA, Watkin KL. Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles. Acad Radiol. 2006;13:421–427
  3. Miyawaki J, Yudasaka M, Imai H, Yorimitsu H, Isobe H, Nakamura E, et al. Synthesis of ultrafine Gd2O3 nanoparticles inside single-wall carbon nanohorns. J Phys Chem B. 2006;110:5179–5181
  4. Hifumi H, Yamaoka S, Tanimoto A, Citterio D, Suzuki K. Gadolinium-based hybrid nanoparticles as a positive MR contrast agent. J Amer Chem Soc. 2006;128:15090–15091
  5. Zhu DH, White RD, Hardy PA, Weerapreeyakul N, Sutthanut K, Jay M. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent. J Nanosci Nanotechnol. 2006;6:996–1003
  6. Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release. 2004;95:613–626
  7. Briley-Saebo KC, Amirbekian V, Mani V, Aguinaldo JGS, Vucic E, Carpenter D, et al. Gadolinium mixed-micelles: effect of the amphiphile on in vitro and in vivo efficacy in apolipoprotein E knockout mouse models of atherosclerosis. Mag Reson Med. 2006;56:1336–1346
  8. Le UM, Cui ZG. Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy. Int J Pharm. 2006;320:96–103
  9. Kobayashi H, Brechbiel MW. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Del Rev. 2005;57:2271–2286
  10. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KCP. Detection of tumor angiogenesis in vivo by alpha(v)beta(3)-targeted magnetic resonance imaging. Nat Med. 1998;4:623–626
  11. Anderson EA, Isaacman S, Peabody DS, Wang EY, Canary JW, Kirshenbaum K. Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett. 2006;6:1160–1164
  12. Crich SG, Bussolati B, Tei L, Grange C, Esposito G, Lanzardo S, et al. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe. Cancer Res. 2006;66:9196–9201
  13. Merbach A, Toth E. The chemistry of contrast agents in magnetic resonance imaging. Chichester, UK: Wiley; 2001;
  14. Paunesku T, Rajh T, Wiederrecht G, Maser J, Vogt S, Stojicevic N, et al. Biology of TiO2-oligonucleotide nanocomposites. Nat Mater. 2003;2:343–346
  15. Paunesku T, Stojicevic N, Vogt S, Maser J, Lai B, Rajh T, et al. Intracellular localization of titanium dioxide-biomolecule nanocomposites. J Physique Iv. 2003;104:317–319
  16. Paunesku T, Vogt S, Lai B, Maser J, Stojicevic N, Thurn KT, et al. Intracellular distribution of TiO(2)-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity. Nano Lett. 2007;7:596–601
  17. Paunesku T, Vogt S, Maser J, Lai B, Woloschak G. X-ray fluorescence microprobe imaging in biology and medicine. J Cell Biochem. 2006;99:1489–1502
  18. Thurn KT, Brown EMB, Wu A, Vogt S, Lai B, Maser J, et al. Nanoparticles for applications in cellular imaging. Nanoscale Res Lett. 2007;2:430–441
  19. Idelson M, Blout ER. Polypeptides. 18. A kinetic study of the polymerization of amino acid N-carboxyanhydrides initiated by strong bases. J Amer Chem Soc. 1958;80:2387–2393
  20. Ke TY, Feng Y, Guo JY, Parker DL, Lu ZR. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging. Mag Reson Imaging. 2006;24:931–940
  21. Rajh T, Chen LX, Lukas K, Liu T, Thurnauer MC, Tiede DM. Surface restructuring of nanoparticles: an efficient route for ligand-metal oxide crosstalk. J Phys Chem B. 2002;106:10543–10552
  22. Michelmore A, Gong WQ, Jenkins P, Ralston J. The interaction of linear polyphosphates with titanium dioxide surfaces. Phys Chem Chem Phys. 2000;2:2985–2992
  23. Vogt S, Maser J, Jacobsen C. Data analysis for X-ray fluorescence imaging. J Physique Iv. 2003;104:617–622
  24. Cacheris WP, Quay SC, Rocklage SM. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging. 1990;8:467–481
  25. Hofmann B, Fischer CO, Lawaczeck R, Platzek J, Semmler W. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol. Invest Radiol. 1999;34:126–133
  26. De Stasio G, Casalbore P, Pallini R, Gilbert B, Sanita F, Ciotti MT, et al. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Res. 2001;61:4272–4277

 This work was supported in part by the following National Institutes of Health grants: CA107467, EB002100, P50 CA89018, U54CA119341; by Department of Energy (DOE) grant FG02-04 ER 63920; and by Siemens Medical Solutions. Use of the Advanced Photon Source was supported by the US DOE, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.

PII: S1549-9634(08)00046-4

doi: 10.1016/j.nano.2008.04.004

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 3 , Pages 201-207 , September 2008